Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma

Clinical trial NCT00813072 · COMPLETED

Trial details

NCT number: NCT00813072
Sponsor: PharmaEngine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stomach Neoplasms Esophageal Neoplasms

Start date: 2007-11-01
Primary completion: 2010-07-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.